Committees and Sections

MITA is organized by the following cross-modality committees and modality-specific sections. These groups are made up of MITA staff and member company representatives that specialize in a given field. For more information or to join a committee, please contact Cheryl Kreider Carey at


  • Coverage Committee


    The Coverage & Research Committee oversees coverage issues related to medical imaging. The goal of the committee is to expand coverage of medical imaging services- for example, through writing of comment letters in response to CMS and USPSTF and drafting of policy statements.

  • Global Affairs Committee


    The Global Affairs Committee addresses the challenges and opportunities MITA members face at a global level.

    The goals of the committee are to limit unnecessary regulatory burdens, work towards international regulatory harmonization, including standards, and expand market access for MITA members.

  • Government Relations

    Government Relations Committee (WashReps)


    The MITA Government Relations Committee develops and implements the legislative strategy for MITA. This committee leads all MITA advocacy efforts before Congress or the administration and also coordinates with other Committees and Sections on shared policy issues on a regular occurrence.

    The goals of the Government Relations Committee are set annually with periodic review and revision occurring at the discretion of its leadership and MITA staff.

    State Government Relations Committee


    The MITA State Government Relations monitors legislative and regulatory activity pertaining to the medical imaging industry. This committee leads all MITA advocacy efforts before state government and regulatory bodies and also coordinates with other Committees and Sections on shared issues on a regular occurrence.

    The goals of the State Government Relations Committee are set annually with periodic review and revision at the discretion of its leadership and MITA staff.

  • Medical Environmental Committee (MEC)


    The Medical Environmental Committee is charged with overseeing the environmental regulatory challenges that uniquely affect the medical imaging industry.

    The goals of the MEC are to improve visibility and knowledge among MITA members of U.S. state and federal regulations and legislation that affect the medical imaging industry, as well as relevant electroindustry initiatives and rationales undertaken by NEMA where those activities might intersect with MITA. The committee also seeks to explore and analyze broader environmental and regulatory trends and challenges that affect electrical and medical imaging product manufacturers more generally (e.g., EU ROHS, recycling mandates) and lead MITA collaboration with counterpart organizations in other regions (e.g., COCIR, MEDEC, JIRA) to address environmental and regulatory challenges and opportunities faced by the global medical imaging industry.

  • Reimbursement Committee


    The Reimbursement Committee oversees federal payment policy issues relating to medical imaging. The goals of this committee are to protect reimbursement and patient access- for example, through the writing of comment letters in response to rulemaking and drafting of policy statements. They also work to develop payment policies which enhance market access to imaging services.

  • Services Committee


    MITA’s Service Committee oversees all standards and regulatory activity associated with the servicing of medical imaging devices. The goal of the Service Committee is to enhance the service marketplace through advocacy, standards development, and other actions as directed by committee membership.

  • Standards Committee


    The MITA Standards Committee provides standards leadership across MITA’s scope of products. MITA is a recognized source of standards and practices that improve patient safety, quality of care, cost of care, interoperability and service efficiency, as well as supporting timely entry of products into the marketplace.

  • Statistical Committee


    The Statistical Committee is charged with overseeing the market data reporting program to ensure its value and relevance to the current medical imaging device market.

    The goals of the Statistical Committee are to review market data reports and give input and suggestions to align the data collection with the current medical imaging device market, review and propose changes to the MITA Board concerning the reporting structure including but not limited to definitions for reporting, reporting categories, participation, and disclosure, and present the MITA Board with proposal(s) for a new market data report(s) for approval and funding.

  • Technical and Regulatory Affairs Committee (TRC)


    The TRC is charged with overseeing MITA’s regulatory activity, including interface with the Food & Drug Administration (FDA), development of comment letters and long term strategy for regulatory work and policy development within MITA. This important committee aims to streamline and improve the regulatory process for bringing medical imaging devices to the market. Only with a transparent, predictable, and timely process can manufacturers pursue technological innovation, provide access for patients to potentially life-saving procedures and compete in the marketplace. In keeping with this mission, and to protect public health, we provide our regulatory expertise and that of member companies to the FDA.We have long emphasized the 510(k) process that determines “substantial equivalence” for clearing the sale of     imaging and radiation devices. In our ongoing dialogue with FDA, we advance our positions and voice industry   concerns about improving the regulatory process.


  • Magnetic Resonance Section (MR)


    The MR Section is charged with overseeing and directing MITA activity specific to magnetic resonance imaging. The MR section serves as a forum for sharing, discussing, and determining action on regulatory and legislative developments to members. Our goal is to enhance the market competitiveness of MR manufacturers and coordinate with stakeholders to promote the highest levels of patient and worker safety and technical expertise.

  • Medical Imaging Informatics Section (MII)


    The Medical Imaging Informatics (MII) Section is charged with overseeing all equipment, components, and accessories used in medical imaging informatics.

    The goals of the MII Section include the creation of policies that help IT manufacturers assess and manage security risks in the safe exchange of healthcare information, the development of a regulatory framework for the regulation of health information technology (HIT), the availability of educational content in the domain of Imaging Informatics and related topics, and the definition of the future of MII by outlining standards, operability, use cases, etc.

  • Molecular (MO) Imaging Section (includes the MITA PET Group)


    Reflecting the holistic nature of this modality, MITA represents the interests of companies that manufacture both the equipment and drugs used in molecular imaging procedures. Importantly, we work to advance policies that encourage growth and innovation within the molecular imaging community.

    We focus on PET and hybrid PET modalities that clinicians utilize to diagnose and manage cancer, heart disease, and neurological disorders. We work with FDA to improve the regulatory environment, and encourage public and private insurers to make appropriate reimbursement decisions. Education is a key component of our activities, as we inform policymakers, physicians, and patients about the appropriate use of PET imaging.

  • Ultrasound Section (UD)


    The Ultrasound Section is charged with overseeing and directing MITA activity specific to ultrasound imaging. The goals of the UD Section are to serve as a forum for sharing, discussing, and determining action on regulatory and legislative developments of importance to members; act as point-of-contact for external enquiries to MITA regarding ultrasound; contribute ultrasound -specific expertise to MITA; increase patient access to new ultrasound technology and applications; and improve safety for workers and patients around ultrasound equipment.

  • X-Ray Section (XR)


    The X-Ray (XR) Section is charged with overseeing MITA work related to products within its scope. Tthis section integrates its four X-ray groups to support diagnostic imaging: conventional and digital X-ray (CR-DR), computed tomography (CT), interventional radiology, and mammography. We provide technical expertise to regulators and medical professionals, develop accreditation and quality control standards, and take proactive steps to improve patient safety.

    The goals of the XR Section include the promotion of safety, interoperability, efficiencies in manufacture, and facilitating understanding about the operation and use of X-ray equipment by developing industry standards and technical documentation. The Section interacts with regulatory agencies and coordinates with other MITA committees when necessary. The XR Section oversees section subgroups and drives coordination of topics that should be addressed at a section level.

  • Imaging Forward

    In just 20 years, medical imaging has dramatically improved health outcomes and lowered costs. Imagine what the future holds. Learn More

  • MITA Smart Initiative

    Promoting patient safety and enhancing the quality of medical imaging technology with MITA Smart Standards. Learn More

  • Fluoro Pharma

    Why I Joined MITA – FluoroPharma Medical, Inc.

    Hear from Thomas Tulip, Ph.D, President, FluoroPharma Medical, Inc. on why his organization joined MITA.

    Learn More